Lactic acid

Generic Name
Lactic acid
Brand Names
Dextrose and Electrolyte No. 75, Dianeal, Dianeal Low Calcium 1.5, Dianeal Pd-2/1.5, Extraneal, Glycerolyte 57, Ionosol-MB, Lactate 1-2-3, Lactated Ringers, Nxstage Pureflow, Physioneal 40, Plasma-lyte R, Prismasol, Ringers
Drug Type
Small Molecule
Chemical Formula
C3H6O3
CAS Number
50-21-5
Unique Ingredient Identifier
3B8D35Y7S4
Background

A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed) Sodium lactate is the sodium salt of lactic acid, and has a mild saline taste. It is produced by fermentation of a sugar source, such as corn or beets, and then, by neutralizing...

Indication

For use as an alkalinizing agent.

Associated Conditions
Corns, Dehydration, Fluid Loss, Hyperkeratosis, Lichenification, Shock, Hypovolemic, Vasoplegic Shock, Verruca (Warts), Mild Metabolic acidosis, Mild, moderate Metabolic Acidosis, Moderate Metabolic acidosis
Associated Therapies
Chemical contraception, Electrolyte replacement, Fluid replacement therapy, Parenteral Nutrition, Peritoneal dialysis therapy, Urine alkalinization therapy
Clinical Trials
Related News

ELI in TBI 24 Hour

Phase 2
Not yet recruiting
Conditions
Traumatic Brain Injury
Interventions
Drug: Sodium Lactate
Drug: placebo
First Posted Date
2024-11-22
Last Posted Date
2024-11-22
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
264
Registration Number
NCT06701760

Study SOLACE SEPSIS

Phase 2
Not yet recruiting
Conditions
Septic Shock
Intracranial Hypertension
Interventions
Drug: 3% NaCl
Drug: Sodium Lactate
First Posted Date
2024-10-09
Last Posted Date
2024-10-14
Lead Sponsor
University Hospital Pilsen
Target Recruit Count
40
Registration Number
NCT06634069
Locations
🇨🇿

University Hospital Pilsen, Pilsen, Czech Republic

Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata

First Posted Date
2024-03-25
Last Posted Date
2024-03-25
Lead Sponsor
Zagazig University
Target Recruit Count
44
Registration Number
NCT06327581
Locations
🇪🇬

Rana Ehab, Zagazig, Egypt

Feasibility of Conducting a Clinical Trial Assessing Efficacy of Lactate as Adjunctive Therapy in Patients With Major Depressive Disorder

Phase 2
Not yet recruiting
Conditions
Major Depressive Disorder
Interventions
Drug: Placebo
Drug: Sodium lactate
First Posted Date
2023-12-13
Last Posted Date
2023-12-13
Lead Sponsor
Centre Hospitalier Universitaire Vaudois
Target Recruit Count
46
Registration Number
NCT06168175

STA363 in the Treatment of Lumbar Disc Herniation

Phase 1
Recruiting
Conditions
Lumbar Disc Herniation
Interventions
Drug: Placebo
Drug: Lactic Acid
First Posted Date
2023-09-01
Last Posted Date
2023-09-01
Lead Sponsor
Stayble Therapeutics
Target Recruit Count
24
Registration Number
NCT06022263
Locations
🇵🇱

Samodzielny Publiczny Szpital Kliniczny nr 4, Klinika Ortopedii i Rehabilitacji, Lublin, Lubelskie, Poland

Hypertonic Lactate After Cardiac Arrest

First Posted Date
2021-08-13
Last Posted Date
2024-12-03
Lead Sponsor
Erasme University Hospital
Target Recruit Count
125
Registration Number
NCT05004610

Sodium Lactate and Brain Relaxation (LSD)

First Posted Date
2020-07-28
Last Posted Date
2023-09-13
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Target Recruit Count
50
Registration Number
NCT04488874
Locations
🇫🇷

CHU de Besançon, Besancon, France

The Effect Lactate Administration on Cerebral Blood Flow During Hypoglycemia

First Posted Date
2018-11-05
Last Posted Date
2018-11-05
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
10
Registration Number
NCT03730909
Locations
🇳🇱

Radoud university medical center, Nijmegen, Netherlands

The Effect of Intravenous Lactate on Brain Lactate Concentrations During Hypoglycemia

First Posted Date
2017-09-19
Last Posted Date
2017-09-19
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
19
Registration Number
NCT03286816
Locations
🇳🇱

Radboud umc, Nijmegen, Netherlands

Exogenous Sodium Lactate Infusion in Traumatic Brain Injury (ELI-TBI)

Phase 2
Withdrawn
Conditions
Brain Injuries, Traumatic
Interventions
Drug: Sodium Lactate
Drug: Placebo
First Posted Date
2016-05-18
Last Posted Date
2021-11-15
Lead Sponsor
University of California, Los Angeles
Registration Number
NCT02776488
Locations
🇺🇸

David Geffen School of Medicine at UCLA, Los Angeles, California, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy